| 摘要 |
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them. |
| 申请人 |
APPLERA CORPORATION;GRAUPE, MICHAEL;LINK, JOHN, O.;ROEPEL, MICHAEL, G. |
发明人 |
GRAUPE, MICHAEL;LINK, JOHN, O.;ROEPEL, MICHAEL, G. |
